Alyeska Investment Group
TNDM icon

Alyeska Investment Group’s Tandem Diabetes Care TNDM Stock Holding History

Alyeska Investment Group’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-50,021
Closed -$3.18M – 535
2019
Q1 		$3.18M Buy
+50,021
New +$2.63M 0.04% 254
2018
Q4 		– Sell
-20,000
Closed -$857K – 468
2018
Q3 		$857K Buy
+20,000
New +$698K 0.01% 358
2018
Q2 		– Hold
0
– – – 533
2018
Q1 		– Sell
-139,196
Closed -$449K – 520
2017
Q4 		$329K Buy
+139,196
New +$437K ﹤0.01% 413
2017
Q2 		– Sell
-160,000
Closed -$1.92M – 551
2017
Q1 		$1.92M Buy
+160,000
New +$3.5M 0.02% 399

Other funds holding TNDM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return